Pernix Therapeutics (PTX) Reports Q4 Net Loss of $81.7M
Get Alerts PTX Hot Sheet
Join SI Premium – FREE
Pernix Therapeutics (NASDAQ: PTX) reported Q4 EPS net loss of $86.1 million, as compared to a net loss of $81.7 million for the three months ended December 31, 2015. Revenue for the quarter came in at $30.1 million, versus $41.5 million reported last year.
“We continue to assess various alternatives in order to proactively address our liquidity and capital structure in a constructive manner, including strategic and refinancing alternatives, asset sales, and mergers and acquisitions.”
For earnings history and earnings-related data on Pernix Therapeutics (PTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi Trends (CTRN) Misses Q4 EPS by 27c, Misses on Revenue; Offers Guidance
- Bit Digital (BTBT) Reports FY EPS of $0.12
- StoneCo (STNE) Tops Q4 EPS by 33c
Create E-mail Alert Related Categories
Corporate News, Earnings, Management CommentsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!